35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron disease in which the loss of spinal cord motor neurons leads to paralysis and death within a few years of clinical disease onset. In almost all cases of ALS, transactive response DNA binding protein of 43 kDa (TDP-43) forms cytoplasmic neuronal inclusions. A second causative gene for a subset of ALS is fused in sarcoma, an RNA binding protein that also forms cytoplasmic inclusions in spinal cord motor neurons. Poly-A binding protein-1 (PABP-1) is a marker of stress granules (i.e. accumulations of proteins and RNA indicative of translational arrest in cells under stress). We report on the colocalization of PABP-1 to both TDP-43 and fused-in-sarcoma inclusions in 4 patient cohorts: ALS without a mutation, ALS with an intermediate polyglutamine repeat expansion in ATXN2, ALS with a GGGGCC hexanucleotide repeat expansion in C9orf72, and ALS with basophilic inclusion body disease. Notably, PABP-1 colocalization to TDP-43 was twice as frequent in ALS with C9orf72 expansions compared to ALS with no mutation. This study highlights PABP-1 as a protein that is important to the pathology of ALS and indicates that the proteomic profile of TDP-43 inclusions in ALS may differ depending on the causative genetic mutation.

          Related collections

          Author and article information

          Journal
          J. Neuropathol. Exp. Neurol.
          Journal of neuropathology and experimental neurology
          Ovid Technologies (Wolters Kluwer Health)
          1554-6578
          0022-3069
          Sep 2014
          : 73
          : 9
          Affiliations
          [1 ] From the Department of Biology, University of Pennsylvania (LM, NMB); Translational Neuropathology Research Laboratory, Stellar Chance Laboratories (EBL); and Department of Pathology and Laboratory Medicine, Perelman School of Medicine (VML, JQT, VMVD, EBL), Philadelphia, Pennsylvania.
          Article
          NIHMS609968
          10.1097/NEN.0000000000000102
          4149258
          25111021
          f54b3306-da1e-4e19-abc5-bff95ac0ef6c
          History

          Comments

          Comment on this article